汉森制药

- 002412

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
汉森制药(002412) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入68,414.1847,167.2425,017.8091,606.2468,115.07
营业收入68,414.1847,167.2425,017.8091,606.2468,115.07
二、营业总成本61,570.0141,511.9120,267.7078,578.5462,225.51
营业成本18,786.4513,401.747,295.9225,590.0319,140.37
营业税金及附加1,366.04942.10473.501,797.691,339.13
销售费用34,681.6222,700.7010,184.5239,603.4734,012.64
管理费用3,524.592,227.911,016.886,477.504,211.28
财务费用199.07123.5866.32319.89221.23
研发费用3,012.242,115.881,230.564,789.963,300.86
资产减值损失----------
公允价值变动收益128.1990.0558.90112.6383.90
投资收益4,410.314,059.761,305.659,157.977,062.59
其中:对联营企业和合营企业的投资收益4,110.203,844.601,229.409,052.797,035.54
汇兑收益----------
三、营业利润11,696.4710,011.846,271.2318,879.0813,638.31
加:营业外收入48.5435.377.9753.8043.18
减:营业外支出36.1032.450.18747.6273.18
其中:非流动资产处置损失----------
四、利润总额11,708.9110,014.766,279.0218,185.2513,608.32
减:所得税费用734.68948.04772.271,423.70600.92
五、净利润10,974.239,066.725,506.7516,761.5513,007.40
归属于母公司所有者的净利润10,974.239,066.725,506.7516,761.5513,007.40
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.21810.18020.10940.33310.2585
稀释每股收益(元/股)0.21810.18020.10940.33310.2585
七、其他综合收益1,127.691,146.83559.14-1,712.64-191.26
八、综合收益总额12,101.9210,213.546,065.8915,048.9212,816.14
归属于母公司所有者的综合收益总额12,101.9210,213.546,065.8915,048.9212,816.14
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶